Project: Promoting atrophic scar repair with elastin mRNA-based therapeutics
| Acronym | RELAST (Reference Number: 12338) |
| Duration | 01/11/2018 |
| Project Topic | We exploit a new drug format, mRNA, for a common dermatological problem, atrophic scars. This allows for the development of a novel, causal treatment based on Elastin replacement, which is reduced in atrophic scars. We will deliver a lead product candidate, ready to enter clinical testing, yielding a comprehensive dossier. This will be used to approach pharmaceutical companies for co-development using an out-licensing model. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 9 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | ACCANIS Biotech F&E GmbH & Co KG | Coordinator | Austria |
| 2 | DATINF GmbH | Partner | Germany |
| 3 | University Hospital Tübingen | Partner | Germany |